Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-137,780
Closed -$1.22M 3224
2022
Q3
$1.22M Hold
137,780
﹤0.01% 2654
2022
Q2
$1.74M Buy
137,780
+7,100
+5% +$90.4K ﹤0.01% 2503
2022
Q1
$2.47M Sell
130,680
-400
-0.3% -$10.2K ﹤0.01% 2401
2021
Q4
$4.6M Buy
131,080
+13,127
+11% +$427K ﹤0.01% 2170
2021
Q3
$4.32M Buy
117,953
+26,606
+29% +$1.05M ﹤0.01% 2294
2021
Q2
$3.59M Buy
91,347
+19,421
+27% +$561K ﹤0.01% 2413
2021
Q1
$2.03M Sell
71,926
-9,037
-11% -$288K ﹤0.01% 2616
2020
Q4
$2.59M Sell
80,963
-4,597
-5% -$141K ﹤0.01% 2380
2020
Q3
$2.76M Sell
85,560
-81,430
-49% -$2.54M ﹤0.01% 2220
2020
Q2
$4.61M Sell
166,990
-10,870
-6% -$236K ﹤0.01% 1939
2020
Q1
$3.17M Buy
177,860
+8,920
+5% +$215K ﹤0.01% 1956
2019
Q4
$4.24M Buy
168,940
+63,483
+60% +$1.39M ﹤0.01% 2075
2019
Q3
$1.88M Buy
105,457
+16,011
+18% +$333K ﹤0.01% 2431
2019
Q2
$1.97M Buy
+89,446
New +$2.55M ﹤0.01% 2445

Other funds holding HCM

Nuveen's HCM Position: Q4 2022 in Review

Nuveen sold out of HUTCHMED (HCM) in Q4 2022, closing a stake of 137,780 shares — an estimated $1.22M sold.

Nuveen first reported a position in HCM in Q2 2019 and held it in 14 quarters. The position peaked at $4.61M in Q2 2020. 84 funds tracked by Wall St. Rank hold HCM as of Q4 2022.

  • Nuveen reported no remaining HUTCHMED position as of Q4 2022 after selling out during the quarter.
  • Nuveen sold 137,780 HUTCHMED shares in Q4 2022, an estimated $1.22M.
  • Nuveen first reported a position in HUTCHMED in Q2 2019 and held it in 14 quarters.
  • Nuveen's HUTCHMED position peaked at $4.61M in Q2 2020.
  • 84 funds tracked by Wall St. Rank held HUTCHMED as of Q4 2022.

Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.